Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|18|2|170-174
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.18, Iss.2, 2018-02, pp. : 170-174
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New Advances in the Study of IgE Drug Recognition
Current Pharmaceutical Design, Vol. 22, Iss. 45, 2017-01 ,pp. :
Access to resources
Recommend
By Dent Gordon
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 10, 2003-10 ,pp. :
IgE, Allergic Diseases, and Omalizumab
Current Pharmaceutical Design, Vol. 12, Iss. 30, 2006-10 ,pp. :
Cetuximab hypersensitivity associated with IgE antibodies
Reactions Weekly, Vol. 1, Iss. 1194-1195, 2008-01 ,pp. :